NASDAQ:CLBS - Caladrius Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$3.68 -0.24 (-6.12 %)
(As of 03/19/2019 04:51 AM ET)
Previous Close$3.92
Today's Range$3.61 - $4.14
52-Week Range$3.05 - $11.65
Volume77,986 shs
Average Volume27,824 shs
Market Capitalization$36.22 million
P/E Ratio-2.07
Dividend YieldN/A
Beta1.85

Analyst Ratings

Caladrius Biosciences (NASDAQ:CLBS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Caladrius Biosciences in the last 12 months. Their average twelve-month price target is $12.75, suggesting that the stock has a possible upside of 246.47%. The high price target for CLBS is $18.50 and the low price target for CLBS is $7.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $12.75$12.75$12.75$11.00
Price Target Upside: 246.47% upside174.78% upside182.08% upside100.00% upside

Caladrius Biosciences (NASDAQ:CLBS) Consensus Price Target History

Price Target History for Caladrius Biosciences (NASDAQ:CLBS)

Caladrius Biosciences (NASDAQ:CLBS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/27/2019Dawson JamesReiterated RatingBuyMediumView Rating Details
1/24/2019HC WainwrightReiterated RatingBuy$18.50LowView Rating Details
8/29/2018Chardan CapitalReiterated RatingBuyHighView Rating Details
(Data available from 3/19/2017 forward)
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel